Answers are grounded in this paper and cite their sources.
This document addresses fibromyalgia from a scientific and clinical perspective, in language intended to be accessible to patients and their families. It examines: the diagnostic criteria of the American College of Rheumatology (2016); the WHO classification of fibromyalgia as a chronic primary pain condition and its explicitly biopsychosocial nature in the ICD-11; the concept of nociplastic pain introduced by the International Association for the Study of Pain in 2017; the pathophysiological mechanisms, including central sensitization, neuroinflammation, and dysregulation of the hypothalamic–pituitary–adrenal axis; the role of psychology in modulating the upstream processes that sustain chronic pain; the evidence on the efficacy of pharmacological and non-pharmacological treatments; and data on long-term prognosis. The aim is to provide accurate, evidence-based information, countering myths and misinformation, and to offer patients concrete tools to understand and manage their condition.
No takes yet. Share an insight, caveat, or question.
Alessandro Mahony (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: